Clinical Trial Update: Propranolol on Post Stroke Immune Status and Infection [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating propranolol's effect on post-stroke immune status and infection risk.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Diseases
• Cardiovascular Diseases
• Central Nervous System Diseases
• Cerebrovascular Disorders
• Nervous System Diseases
• Stroke

Drugs mentioned

• Propranolol (propranolol)

Snippet

Sponsor: Tianjin Medical University General Hospital | Conditions: Stroke, Cerebrovascular Disorders | Phase 2 | Status: UNKNOWN